Archive

Researchers discover how lactic acid weakens anti-tumor defenses

Written by Charlie King | 3 Feb 2022

In cancer research, it has long been known that lactic acid, or lactate, is produced in large quantities by cancer cells and that this lactic acid disrupts our… read more.

Lung cancer – urgent action required to get back on track

Written by Christine Clark | 3 Feb 2022

Two recent reports show how hard lung cancer outcomes have been impacted as a result of the covid-19 pandemic, according to Professor Robert Rintoul, chair of the UK… read more.

European Commission approves Lenvima + Keytruda to treat endometrial carcinoma – Eisai + Merck Inc.

Written by Charlie King | 29 Jan 2022

Eisai Co., Ltd. and Merck Inc., announced that the European Commission has approved the combination of Lenvima, the orally available multiple receptor tyrosine kinase inhibitor discovered by Eisai,… read more.

Researchers develop optical biopsy system that detects liver cancer

Written by Charlie King | 20 Jan 2022

New instrument could aid diagnosis by helping surgeons pinpoint the best place for a biopsy. Researchers have developed an optical biopsy system that can distinguish between cancerous and… read more.

Glucose control lowers risk of cancer in obese diabetic patients

Written by Bruce Sylvester | 18 Jan 2022

Blood glucose control is key to lowering the risk of cancer in obese persons with type 2 diabetes, researchers reported on Dec. 6, 20231 in Diabetes Care. “What… read more.

Possibility of vaccine to prevent skin cancer

Written by Charlie King | 17 Jan 2022

Research by the Oregon State University College of Pharmacy suggests that a vaccine stimulating production of a protein critical to the skin’s antioxidant network could help people bolster… read more.

Sorting cancers by ‘immune archetypes’ represents potential new approach to developing precision immunotherapies

Written by Charlie King | 16 Jan 2022

Common immune microenvironments across different types of cancer. Using data from over 300 patient tumors, researchers have described 12 classes of ‘immune archetypes’ to classify cancer tumors. Their… read more.

Could umbilical cord stem cells cure blood cancer?

Written by Gary Finnegan | 9 Jan 2022

Stem cells have promised to be the catalyst for major strides in medical research for decades. While progress in some fields has been slower than initially hoped, scientists… read more.

Sloan Kettering Institute scientists design CAR T cells to activate cancer pro-drugs at the disease site

Written by Christine Clark | 8 Jan 2022

Immunotherapies called chimeric antigen receptor (CAR) T cells use genetically engineered versions of a patient’s own immune cells to fight cancer. These treatments have energized cancer care, especially for people… read more.

Cancer deaths rose to 10 million worldwide in 2019

Written by Charlie King | 7 Jan 2022

Recent trends also highlight global disparities in cancer burden. Cancer deaths rose to 10 million and new cases jumped to over 23 million globally in 2019, according to… read more.

Radiation monotherapy shows efficacy for treating oligometastatic renal cell carcinoma

Written by Bruce Sylvester | 27 Dec 2021

Radiation monotherapy is an effective noninvasive treatment for oligometastatic renal cell carcinoma (RCC), researchers reported on Oct. 28, 2021 in The Lancet Oncology. “These findings are exciting because… read more.

Supermeres’ may carry clues to cancer, Alzheimer’s disease and COVID-19

Written by Charlie King | 24 Dec 2021

Researchers at Vanderbilt University Medical Center have discovered a nanoparticle released from cells, called a “supermere,” which contains enzymes, proteins and RNA associated with multiple cancers, cardiovascular disease,… read more.

« Previous 1 … 15 16 17 18 19 … 37 Next »

Archive

Subscribe for our mailing list

Follow Us